Matinas Biopharma logo

Matinas Biopharma share price today

(MTNB)

Matinas Biopharma share price is $0.73 & ₹62.64 as on 7 Jan 2025, 2.30 'hrs' IST

$0.73

0.1

(15.59%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Matinas Biopharma share price in Dollar and Rupees. Guide to invest in Matinas Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Matinas Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Matinas Biopharma share price movements

  • Today's Low: $0.65
    Today's High: $0.80

    Day's Volatility :18.3%

  • 52 Weeks Low: $0.48
    52 Weeks High: $21.50

    52 Weeks Volatility :97.78%

Matinas Biopharma Returns

PeriodMatinas Biopharma Holdings IncIndex (Russel 2000)
3 Months
-80.7%
0.0%
6 Months
-92.21%
0.0%
1 Year
-94.32%
0.0%
3 Years
-98.63%
-19.8%

Matinas Biopharma Key Statistics

in dollars & INR

Previous Close
$0.635
Open
$0.6784
Today's High
$0.7956
Today's Low
$0.65
Market Capitalization
$2.6M
Today's Volume
$206.1K
52 Week High
$21.5
52 Week Low
$0.478
Revenue TTM
$0.0
EBITDA
$-23.4M
Earnings Per Share (EPS)
$-4.74
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-97.59%

How to invest in Matinas Biopharma from India?

It is very easy for Indian residents to invest directly in Matinas Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Matinas Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Matinas Biopharma or MTNB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Matinas Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Matinas Biopharma shares which would translate to 1.175 fractional shares of Matinas Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Matinas Biopharma, in just a few clicks!

Returns in Matinas Biopharma for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Matinas Biopharma investment value today

Current value as on today

₹9,752

Returns

₹90,248

(-90.25%)

Returns from Matinas Biopharma Stock

₹93,470 (-93.47%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Matinas Biopharma

-60%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Matinas Biopharma on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -60% less investors are searching Matinas Biopharma in the last 30 days versus the previous period.

Analyst Recommendation on Matinas Biopharma

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Matinas Biopharma(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Matinas Biopharma

What analysts predicted

Upside of 4009.59%

Current:

$0.73

Target:

$30.00

Insights on Matinas Biopharma

  • Price Movement

    In the last 7 days, MTNB stock has moved up by 22.6%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.09M → -1.09M (in $), with an average decrease of 200.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -5.82M → -4.27M (in $), with an average increase of 17.8% per quarter
  • MTNB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 117.8%
  • MTNB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 153.9%

Matinas Biopharma Technicals Summary

Sell

Neutral

Buy

Matinas Biopharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Matinas Biopharma Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Matinas Biopharma Holdings Inc
4.0%
-92.21%
-94.32%
-98.63%
-99.34%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Matinas Biopharma Holdings Inc
NA
NA
0.0
-4.06
-0.98
-0.51
NA
4.43
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Matinas Biopharma Holdings Inc
Buy
$2.6M
-99.34%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Matinas Biopharma

matinas biopharma (nyse mkt: mtnb) is a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications. the company's proprietary, disruptive technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, making them safer, more tolerable, less toxic and orally bioavailable. the company's lead drug candidate mat2203, currently in phase 2, is an orally-administered, encochleated formulation of amphotericin b (a broad spectrum fungicidal agent). the company has an open investigational new drug (ind) application for mat2501, currently in phase 1, which is an orally-administered, encochleated formulation of amikacin (a broad spectrum aminoglycoside antibiotic agent) for acute bacterial infections, including non-tuberculous mycobacterium (ntm) and multi-drug resistant gram negative bacterial infections. the company's lead anti-infective product candidates, mat2203 and mat2501, position matinas biopharma to bec
Organization
Matinas Biopharma
Employees
32
CEO
Mr. Jerome D. Jabbour J.D.
Industry
Health Technology

Management People of Matinas Biopharma

NameTitle
Mr. Jerome D. Jabbour J.D.
Co-Founder, CEO, President & Director
Mr. Keith A. Kucinski CPA, M.B.A.
Chief Financial Officer
Mr. Frank Calamusa
Executive Director and Head of Manufacturing & Supply Chain

Important FAQs about investing in Matinas Biopharma from India :

What is Matinas Biopharma share price today?

Matinas Biopharma share price today stands at $0.73, Open: $0.68 ; Previous Close: $0.64 ; High: $0.80 ; Low: $0.65 ; 52 Week High: $21.50 ; 52 Week Low: $0.48. The stock opens at $0.68, after a previous close of $0.64. The stock reached a daily high of $0.80 and a low of $0.65, with a 52-week high of $21.50 and a 52-week low of $0.48.

Can Indians buy Matinas Biopharma shares?

Yes, Indians can invest in the Matinas Biopharma (MTNB) from India.

With INDmoney, you can buy Matinas Biopharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Matinas Biopharma at zero transaction cost.

How can I buy Matinas Biopharma shares from India?

It is very easy to buy Matinas Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Matinas Biopharma be purchased?

Yes, you can buy fractional shares of Matinas Biopharma with INDmoney app.

What are the documents required to start investing in Matinas Biopharma stocks?

To start investing in Matinas Biopharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Matinas Biopharma

Today’s highest price of Matinas Biopharma (MTNB) is $0.80.

Today’s lowest price of Matinas Biopharma (MTNB) is $0.65.

What is today's market capitalisation of Matinas Biopharma

Today's market capitalisation of Matinas Biopharma MTNB is 2.6M

What is the 52 Week High and Low Range of Matinas Biopharma

  • 52 Week High

    $21.50

  • 52 Week Low

    $0.48

What are the historical returns of Matinas Biopharma?

  • 1 Month Returns

    4%

  • 3 Months Returns

    -92.21%

  • 1 Year Returns

    -94.32%

  • 5 Years Returns

    -99.34%

Who is the Chief Executive Officer (CEO) of Matinas Biopharma

Mr. Jerome D. Jabbour J.D. is the current Chief Executive Officer (CEO) of Matinas Biopharma.